BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 9643126)

  • 1. [Post-exposure HIV prevention within and outside the hospital].
    Jost J
    Ther Umsch; 1998 May; 55(5):289-94. PubMed ID: 9643126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
    Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
    Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registry finds 3 drugs most favored PEP regimen.
    AIDS Alert; 1998 Jul; 13(7):75-6. PubMed ID: 11365586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV].
    Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
    Radiologe; 2004 Feb; 44(2):181-94. PubMed ID: 14991139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-exposure prevention of HIV infection].
    Möst J
    Wien Med Wochenschr; 1998; 148(23-24):547-9. PubMed ID: 10189684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postexposure prophylaxis for HIV.
    Daily JP
    AIDS Clin Care; 1997 Aug; 9(8):59-61, 66. PubMed ID: 11364478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-occupational exposure HIV infection in health workers: an update and preventive measures].
    Boaventura JL
    Acta Med Port; 1997; 10(6-7):469-78. PubMed ID: 9341039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
    Cardo DM; Culver DH; Ciesielski CA; Srivastava PU; Marcus R; Abiteboul D; Heptonstall J; Ippolito G; Lot F; McKibben PS; Bell DM
    N Engl J Med; 1997 Nov; 337(21):1485-90. PubMed ID: 9366579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues on antiretroviral post exposure combination prophylaxis.
    Puro V; Ippolito G
    J Biol Regul Homeost Agents; 1997; 11(1-2):11-9. PubMed ID: 9418155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure].
    Sudre P; San Millán Ruiz D; Fagard C; Perrin L; Hirschel BJ
    Schweiz Med Wochenschr; 1999 Feb; 129(8):314-8. PubMed ID: 10189668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated postexposure guidelines stress need for expert advice.
    AIDS Alert; 1998 Jul; 13(7):73-5. PubMed ID: 11365585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prone occupational exposures: epidemiology and factors associated with initiation of post-exposure prophylaxis.
    Zenner D; Tomkins S; Charlett A; Wellings K; Ncube F
    J Epidemiol Community Health; 2009 May; 63(5):373-8. PubMed ID: 19188197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEPping up your HIV defenses.
    Torres G
    GMHC Treat Issues; 1998 May; 12(5):8-9. PubMed ID: 11365480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational postexposure prophylaxis for HIV: The PEPline perspective.
    Top HIV Med; 2010 Dec; 18(5):174-7. PubMed ID: 21245519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.